Cytarabine FDA Link Generic

A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472)

Also Known As:

Cytosar-U; Cytosine Arabinoside; Aracytidine; Aracytine; Cytarabine Hydrochloride; Cytonal; Cytosar; beta-Ara C; Ara C; Arabinoside, Cytosine; Cytosar U; beta Ara C; Ara-C; Arabinofuranosylcytosine; Arabinosylcytosine; 2(1H)-Pyrimidinone, 4-amino-1-beta-D-arabinofuranosyl-

Pharmalogical Action Categories:

Antimetabolites, Antineoplastic
Antiviral Agents
Immunosuppressive Agents

Heterocyclic Compounds: 207
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 521
    - Pyrimidine Nucleosides: 50
      - Cytidine: 548
        Cytarabine: 6746
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6937
  - Pyrimidine Nucleosides: 50
    - Cytidine: 548
      - Cytarabine: 6746
  - Arabinonucleosides: 1
    - Cytarabine: 6746

Thierry LeBlanc Selected Research

Thierry LeBlanc Research Topics

Disease

Drug/Important Bio-Agent (IBA)

Therapy/Procedure